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What is the best way to diagnose 
polycystic ovarian syndrome?
n Evidence summary
Polycystic ovarian syndrome is a condi-
tion of unexplained hyperandrogenic
chronic anovulation that affects at least
4% of women of reproductive age.1
Because PCOS is a clinical syndrome, no
single diagnostic criterion is sufficient for
diagnosis.2 Clinical features include men-
strual irregularities or infertility, hirsutism,
male-pattern balding, acne, ovarian
enlargement, and signs of insulin resist-
ance (eg, central obesity, acanthosis nigri-
cans). A 2003 international consensus
panel concluded that the presence of 2 of
3 criteria (oligo/anovulation, hyperandro-
genism, polycystic ovaries), in the absence
of other secondary causes, is sufficient to
make the diagnosis.2 Evidence for hyper-
androgenism includes hirsutism, acne, or
elevated total testosterone levels.3 A high
luteinizing hormone/follicle-stimulating
hormone (LH/FSH) ratio supports the
C L I N I C A L C O M M E N T A R Y
Faty liver and insulin resistance are common 
problems in patients with PCOS
Today we have a better understanding of the rela-
tion between obesity, insulin resistance, and poly-
cystic ovarian syndrome (PCOS), but it is not quite
clear whether the insulin resistance plays the main
pathophysiologic role in this condition. As the
prevalence of obesity, metabolic syndrome, and
diabetes increases in our society, it is expected 
that the incidence of PCOS will rise as well. 
Unfortunately, there is no single specific 
diagnostic test available for the diagnosis of PCOS. 
I practice in a community clinic where access to
pelvic ultrasound is limited, and often I have to
rely on laboratory analysis to make the diagnosis.
Aside from TSH, prolactin, DHEA sulfate, 17 OHP,
free testosterone, LH/FSH, and lipid panel, I calcu-
late insulin resistance (IR) using fasting blood sugar
and insulin level. If the IR level is elevated, I counsel
the patient about PCOS and refer her to a dietitian
for weight management while waiting for a pelvic
ultrasonography appointment. However, due to
multiple limitations that apply to the measurement
of IR, experts in this field do not recommend its
widespread use for the diagnosis of PCOS.
I also find that elevated ALT is not uncommon
among my overweight patients who present with
PCOS related symptoms. Further workup in this
group of patients usually leads to the diagnosis of
fatty infiltration of the liver. 
Pouran Yousefi, MD
Baylor College of Medicine, Houston, Texas
Polycystic ovarian syndrome (PCOS) is diagnosed
for women of childbearing age presenting with 2
of the following: 1) oligo- or anovulatory menstrual
irregularities, 2) evidence of hyperandrogenism 
in the absence of secondary cause; 3) enlarged
ovaries with multiple small follicular cysts on
transvaginal ultrasound (strength of recommen-
dation [SOR]: C, based on expert opinion).
Depending on the clinical presentation, 
secondary causes should be excluded (TABLE)
(SOR: C, expert opinion). While not among the
diagnostic criteria, insulin resistance is common,
and patients with PCOS should be evaluated for
metabolic abnormalities, particularly hyperlipi-
demia and glucose intolerance or diabetes 
(SOR: B, based on prospective cohort studies).
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diagnosis. However, because this measure
varies considerably in relation to ovula-
tion, body-mass index (BMI), and the par-
ticular measurement assay used, the con-
sensus panel recommended against its use
as a diagnostic criterion.2 Based on opti-
mum receiver operator characteristic
curve analyses, ultrasound criteria include
the presence of 12 or more follicles in each
ovary measuring 2 to 9 mm in diameter
(sensitivity=75%, specificity=99%, posi-
tive predictive value [PPV]=75%, negative
predictive value [NPV]= 99%, assuming
4% prevalence) or ovarian volume over 
7 mL (sensitivity=67.5%, specificity=
91.2%, PPV=24%, NPV 99%).4,5
PCOS is also a diagnosis of exclusion.
Secondary causes of hyperandrogenism
may be suggested by clinical findings,
including 1) abrupt onset, short duration,
or sudden progressive worsening of hir-
sutism; 2) onset of symptoms in the third
decade of life or later; or 3) signs of viril-
ization (deepening voice, clitoromegaly).6
The differential diagnosis, clinical fea-
tures and potentially useful diagnostic
tests to rule out secondary causes are
shown in the TABLE.
Women with PCOS often experience
insulin resistance, and are at increased risk
for developing type 2 diabetes, dyslipi-
demia, and cardiovascular disease. One
cross-sectional study7 of 122 women with
PCOS between 13.5 and 40 years of age
found that 35% had impaired glucose tol-
erance, and another 10% had non-insulin-
dependent diabetes. A prospective case-
control study8 of young women (aged <35
years) found that compared with age- and
BMI-matched controls, those with PCOS
had higher levels of fasting glucose, insulin,
total and low-density lipoprotein choles-
terol, and altered left ventricular mass and
cardiac function on echocardiogram. Once
PCOS is suspected, the diagnostic work-up
should include a 2-hour glucose tolerance
test and lipid panel to assess cardiovascu-
lar risk, particularly among obese women.
Recommendations from others
A 2002 American College of Obstetricians
and Gynecologists guideline9 adopted the
1990 National Institutes of Health consen-
sus panel criteria for diagnosing PCOS (ie,
chronic anovulation and clinical or bio-
chemical signs of hyperandrogenism,
If PCOS is 
suspected,
workup should
include a glucose
tolerance test 
and lipid panel
FAST TRACK
T A B L E
DIFFERENTIAL DIAGNOSES CLINICAL FEATURES TEST
Nonclassical congenital Family history; more common 17-hydroxyprogesterone
adrenal hyperplasia among Ashkenazi Jews
Androgen-secreting Rapid virilization DHEA-S (adrenal)
neoplasms Testosterone (ovary)
Hypothyroidism Fatigue, dry skin, cold intolerance, Thyroid-stimulating
weight gain, constipation, goiter hormone
Hyperprolactinemia Galactorrhea Prolactin (may be mildly
high in PCOS)
Cushing syndrome (rare) Moon face, buffalo hump, 24 hour urine free cortisol
abdominal striae, centripetal fat Dexamethasone suppression
pattern, hypertension, easy bruising test (confirmatory)
Acromegaly Acral enlargement, coarse  Insulin-like growth factor
features, prognathism
Adapted from Chang, Am J Obstet Gynecol 2004.6
Differential diagnosis of hyperandrogenism in PCOS
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excluding other causes), and recommends
that all patients have documentation of
elevated testosterone levels; thyroid-stimu-
lating hormone (TSH), prolactin, and 17-
hydroxyprogesterone levels to exclude 
secondary causes of hyperandrogenism;
and evaluation for metabolic abnormali-
ties with a 2-hour glucose tolerance test
and fasting lipid panel. 
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